Awards + Announcements

The Whitehead Institute Board of Directors has elected Maren Winnick, a leader in biopharma investment banking, for a six-year term beginning January 1, 2025. 

Andy Tseng will join the Institute on January 13, 2025 as Director of Information Technology (IT) and Digital Strategy for Whitehead Institute. In that role, he will oversee the Institute's IT operations and digital initiatives, and will help Whitehead scientists and staff leverage advanced AI technologies and innovative IT solutions to accelerate scientific discovery while ensuring data security and privacy.

We invite you to explore our 2024 Annual Report, and learn about the work we are doing, the scientific advances we are making, and our diverse and collaborative community.

The American Society of Tropical Medicine and Hygiene (ASTMH) selected Whitehead Institute Member Sebastian Lourido to receive its 2024 William Trager Award. 

Whitehead Fellow Aditya Raguram has received a 2024 NIH Director’s Early Independence Award. The prestigious funding award will support his work developing cell-derived bioparticles into safe and efficient vehicles for delivering therapeutic proteins into cells. 

Whitehead Institute has appointed Na Sun, a 2024 PhD graduate of Massachusetts Institute of Technology (MIT), as the inaugural AI Fellow within the Whitehead Fellows Program.

The Whitehead Institute together with the Department of Biology at the Massachusetts Institute
of Technology (Cambridge, Massachusetts) invites applications for a tenure-track appointment at
the Assistant Professor level.

Whitehead Institute graduate student researchers Christopher Giuliano and Julian Roessler have been awarded the 2024 Regeneron Prize for Creative Innovation. In addition, postdoctoral researcher Chen Weng was selected as a finalist in the postdoctoral fellows competition.

Whitehead Institute Member Mary Gehring has been selected as an Investigator of the Howard Hughes Medical Institute (HHMI), one of just 26 scientists appointed in 2024.

The Whitehead Institute Board of Directors has elected two experienced leaders to its ranks: biotechnology and pharmaceutical industry executive Dr. Deborah Dunsire; and Micho Spring, a strategic communications expert who led a major global consulting practice.